CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability.
Elfatih Elzein, Prabha Ibrahim, Dmitry O Koltun, Ken Rehder, Kevin D Shenk, Timothy A Marquart, Bob Jiang, Xiaofen Li, Reina Natero, Yuan Li, Marie Nguyen, Suresh Kerwar, Nancy Chu, Daniel Soohoo, Jia Hao, Victoria Y Maydanik, David A Lustig, Dewan Zeng, Kwan Leung, Jeff A Zablocki
文献索引:Bioorg. Med. Chem. Lett. 14 , 6017-6021, (2004)
全文:HTML全文
摘要
New inhibitors of palmitoyl-CoA oxidation are based on the introduction of nitrogen heterocycles in the 'Western Portion' of the molecule. SAR studies led to the discovery of CVT-4325 (shown), a potent FOXi (IC50=380 nM rat mitochondria) with favorable PK properties (F=93%, t(1/2)=13.6h, dog).
相关化合物
相关文献:
2013-04-17
[ACS Chem. Neurosci. 4(4) , 624-34, (2013)]
A new synthesis of 1, 2, 4-triazolin-5-ones: application to the convergent synthesis of an NK 1 antagonist. Cowden CJ, et al.
[Tetrahedron Lett. 41(44) , 8661-64, (2000)]